Combined effects of different interleukin-28B gene variants on the outcome of dual combination therapy in chronic hepatitis C virus type 1 infection
出版年份 2012 全文链接
标题
Combined effects of different interleukin-28B gene variants on the outcome of dual combination therapy in chronic hepatitis C virus type 1 infection
作者
关键词
-
出版物
HEPATOLOGY
Volume 55, Issue 6, Pages 1700-1710
出版商
Wiley
发表日期
2012-01-11
DOI
10.1002/hep.25582
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Improved Responses to Pegylated Interferon Alfa-2b and Ribavirin by Individualizing Treatment for 24–72 Weeks
- (2011) Christoph Sarrazin et al. GASTROENTEROLOGY
- High-Dose Pegylated Interferon-α and Ribavirin in Nonresponder Hepatitis C Patients and Relationship With IL-28B Genotype (SYREN Trial)
- (2011) Stéphane Chevaliez et al. GASTROENTEROLOGY
- Estimating the net contribution of interleukin-28B variation to spontaneous hepatitis C virus clearance
- (2011) Julia di Iulio et al. HEPATOLOGY
- IL28B polymorphisms predict reduction of HCV RNA from the first day of therapy in chronic hepatitis C
- (2011) P.-Y. Bochud et al. JOURNAL OF HEPATOLOGY
- IL28B single nucleotide polymorphisms in the treatment of hepatitis C
- (2011) Christian M. Lange et al. JOURNAL OF HEPATOLOGY
- Genetic Variation in IL28B and Treatment-induced Clearance of Hepatitis C Virus in HIV-Positive Patients With Acute and Chronic Hepatitis C
- (2011) J. Nattermann et al. JOURNAL OF INFECTIOUS DISEASES
- The role of genetic markers in hepatitis C virus therapy: a major step for individualized care
- (2011) John G. McHutchison LIVER INTERNATIONAL
- IL28B SNP rs12979860 Is a Critical Predictor for On-Treatment and Sustained Virologic Response in Patients with Hepatitis C Virus Genotype-1 Infection
- (2011) Chun-Yen Lin et al. PLoS One
- Identification of improved IL28B SNPs and haplotypes for prediction of drug response in treatment of hepatitis C using massively parallel sequencing in a cross-sectional European cohort
- (2011) Katherine R Smith et al. Genome Medicine
- Impact of IL28B Genotype on the Early and Sustained Virologic Response in Treatment-Naïve Patients With Chronic Hepatitis C
- (2010) Albert Friedrich Stättermayer et al. Clinical Gastroenterology and Hepatology
- Interleukin-28B Polymorphism Improves Viral Kinetics and Is the Strongest Pretreatment Predictor of Sustained Virologic Response in Genotype 1 Hepatitis C Virus
- (2010) Alexander J. Thompson et al. GASTROENTEROLOGY
- A Polymorphism Near IL28B Is Associated With Spontaneous Clearance of Acute Hepatitis C Virus and Jaundice
- (2010) Hans L. Tillmann et al. GASTROENTEROLOGY
- Replicated Association Between an IL28B Gene Variant and a Sustained Response to Pegylated Interferon and Ribavirin
- (2010) Jeanette J. McCarthy et al. GASTROENTEROLOGY
- Hepatic ISG Expression Is Associated With Genetic Variation in Interleukin 28B and the Outcome of IFN Therapy for Chronic Hepatitis C
- (2010) Masao Honda et al. GASTROENTEROLOGY
- Genetic Variation in IL28B Is Associated With Chronic Hepatitis C and Treatment Failure: A Genome-Wide Association Study
- (2010) Andri Rauch et al. GASTROENTEROLOGY
- IL28B and the Control of Hepatitis C Virus Infection
- (2010) Ashwin Balagopal et al. GASTROENTEROLOGY
- IL28B genotype is associated with differential expression of intrahepatic interferon-stimulated genes in patients with chronic hepatitis C
- (2010) Thomas J. Urban et al. HEPATOLOGY
- Potential role for Interleukin-28B genotype in treatment decision-making in recent hepatitis C virus infection
- (2010) Jason Grebely et al. HEPATOLOGY
- Amino acid substitution in hepatitis C virus core region and genetic variation near the interleukin 28B gene predict viral response to telaprevir with peginterferon and ribavirin
- (2010) Norio Akuta et al. HEPATOLOGY
- Interleukin-28B genetic variants and hepatitis virus infection by different viral genotypes
- (2010) Marco Antonio Montes-Cano et al. HEPATOLOGY
- IL28 variation affects expression of interferon stimulated genes and peg-interferon and ribavirin therapy
- (2010) Hiromi Abe et al. JOURNAL OF HEPATOLOGY
- IL28B inhibits hepatitis C virus replication through the JAK–STAT pathway
- (2010) Leiliang Zhang et al. JOURNAL OF HEPATOLOGY
- Type III IFNs: New layers of complexity in innate antiviral immunity
- (2009) Nina Ank et al. BIOFACTORS
- Individualized treatment strategy according to early viral kinetics in hepatitis C virus type 1-infected patients
- (2009) Thomas Berg et al. HEPATOLOGY
- Interferon-λ Is Functionally an Interferon but Structurally Related to the Interleukin-10 Family
- (2009) Hans Henrik Gad et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Viral factors influencing the response to the combination therapy of peginterferon plus ribavirin in chronic hepatitis C
- (2009) Shinya Maekawa et al. JOURNAL OF GASTROENTEROLOGY
- Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
- (2009) Dongliang Ge et al. NATURE
- Genetic variation in IL28B and spontaneous clearance of hepatitis C virus
- (2009) David L. Thomas et al. NATURE
- IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy
- (2009) Vijayaprakash Suppiah et al. NATURE GENETICS
- Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C
- (2009) Yasuhito Tanaka et al. NATURE GENETICS
- Host genetic determinants of spontaneous hepatitis C clearance
- (2009) Andri Rauch et al. PHARMACOGENOMICS
- Host Genetic Factors and Antiviral Immune Responses to Hepatitis C Virus
- (2008) Chloe L. Thio Clinics in Liver Disease
- Human interferon-λ3 is a potent member of the type III interferon family
- (2008) C Dellgren et al. GENES AND IMMUNITY
- Expert opinion on the treatment of patients with chronic hepatitis C
- (2008) S. Zeuzem et al. JOURNAL OF VIRAL HEPATITIS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started